The oncoprotein E2A-Pbx1a collaborates with Hoxa9 to acutely transform primary bone marrow cells

Pharmacology, Toxicology and Pharmaceutical Science

• Oncoprotein 100%
• Diseases 50%
• Carcinogenesis 50%
• Cytokine 50%
• Synergism 50%
• Growth Factor 50%
• Granulocyte Colony Stimulating Factor 50%
• Acute Leukemia 50%
• Gene Delivery 50%
• Hox Protein 50%
• Interleukin 3 50%
• Murine Leukemia 50%